Abstract:Objective The purpose of this study was to investigate the clinical significance of serum vascular endothelial growth factor(S-VEGF)in patients of esophageal squamous cell carcinoma with the end-point of progress-free survival rate.Methods Sera from 89 patients with esophageal squamous carcinoma,who presented and treated with concurrent chemoradiotherapy or surgical resection in Cancer Center d Sun Yat-Sen University from December 2002 to May 2004,were sampled at the time of pre-treatment.30 cases of health individuals without any evidence of disease were selected as control group.For patients with surgical resection were performed with esophagectomy and extended lymphadenectomy.For patients with concurrent chemoradiotherapy comprised of cisplatin and 5-fluorouracil.The radiotherapy dose of 2 Gy per day was initiated on Day 1 of chemotherapy and continued daily for 5 days per week for 6 weeks,for a total close of 60 Gy.Two courses of chemotherapy were given during radiotherapy at 6-week intervals.The serum vascular endothelial growth factor(S- VEGF)levels were measured with a solid phase enzyme Human VEGF Immunoassay ELISA kit.The end point of this study was progress-free survival,and time was calculated from the date of diagnosis to date of relapse or last follow evaluation.Results S-VEGF level of patients with esophageal squamous cell carcinoma was significantly higher than that of heahhy controls(475.93±44.76 pg/ml vs.294.20±23.40 pg/ml;P=0.020).S-VEGF levels in patients with StageⅢand StageⅣdisease were significantly higher than those in patients with Stage I and StageⅡdisease.The 1-year progress-free survival rate d high S-VEGF group(≥475 pg/ml)was significantly lower than that of the low S-VEGF group(＜475 pg/ml)(24% vs.66%;P=0.0004).The 1-year progress-free survival rate of the patients with StageⅠand StageⅡdisease was significantly higher than that of patients with StageⅢand StageⅣdisease(71% vs.29%;P=0.0015).The variables were assessed by multivariate analysis using the Cox proportional hazards model,and the results revealed that the clinical stage and the S-VEGF were first and second independent prognosis factor,respectively.Conclusions In the current study,a high S-VEGF was found to be associated with tumor progression,poor treatment response,and poor survival in patients with squamous cell carcinoma of the esophagus.

Study on Serum Vascular Endothelial Growth Factor-C Level in Patients with Primary Human Esophageal Squamous Cell Carcinomas-A Possible Marker of Lymph Node Metastasis

Vascular Endothelial Growth Factor C is an Indicator of Lymph Node Metastasis in Thoracic Esophageal Squamous Cell Carcinomas and Its Role in Long‐term Survival after Surgery

Serum spleen tyrosine kinase and vascular endothelial growth factor-C levels predict lymph node metastasis of oesophageal squamous cell carcinoma

The Relationship Between Plasma Vascular Endothelial Growth Factor and Clinicopathological Parameters in Patients with Esophageal Squamous Cell Carcinoma

Expression and clinical study of vascular endothelial growth factor and its receptors FLT-1, FLK-1/KDR in non-small cell lung cancer

VEGF-C Expression and Clinical Significance in Esophageal Squamous Cell Carcinoma

[VEGF-C Mrna Expression and Its Relationship with Clinicopathological Parameters in Esophageal Squamous Cell Carcinoma].

[Expression of Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor Receptor-3 and Nm23-H1 in Oral Squamous Cell Carcinoma].

Effects of lymphatic growth factor on angiogenesis,tumor metastasis and prognosis in esophageal squamous cell carcinoma

Expression of VEGF-D in esophageal squamous cell carcinoma and the correlation with lymphatic vessel density and lymphatic metastasis

Clinical Significance of S-VEGF in Patients with Esophageal Cancer

Vascular Endothelial Growth Factor is a Useful Predictor of Postoperative Distant Metastasis and Survival Prognosis in Esophageal Squamous Cell Carcinoma

[Expression of Vascular Endothelial Growth Factor C in Laryngeal Squamous Carcinoma and Its Role in Lymphatic Metastasis].

Expression and clinicopathological significance of VEGF -C in esophageal squamous cell carcinoma

CyclinD1, P53, E-cadherin, and VEGF Discordant Expression in Paired Regional Metastatic Lymph Nodes of Esophageal Squamous Cell Carcinoma: a Tissue Array Analysis.

[Relationship Between Clinicopathologic Characteristics and Expression of VEGF-C and VEGF-D in Esophageal Squamous Cancer].

Expression of VEGF-C correlates with a poor prognosis based on analysis of prognostic factors in 73 patients with esophageal squamous cell carcinomas.

Expressions of Vascular Endothelial Growth Factor and Non-Metastasis 23 in Eesophageal Squamous Cell Carcinoma and Their Clinical Significance

Effect of concurrent chemoradiotherapy on serum vascular endothelial growth factor in esophageal squamous cell carcinoma patients--a report of 43 cases]

Clinical significance of detecting circulating tumor cells in patients with esophageal squamous cell carcinoma by EpCAM‑independent enrichment and immunostaining‑fluorescence in situ hybridization

Expression and Clinical Significance of NF - Κb and VEGF - C in Esophageal Squamous Cell Carcinoma